170 results
Page 3 of 9
6-K
EX-99.1
judowqy1kfzg
17 Aug 22
Current Report
8:02am
6-K
EX-99.1
7fuf61a 9i74fpx
3 Aug 22
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
tqf bkmiifbp
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
7k8u10
6 Jun 22
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
62ojz
31 May 22
Report of Foreign Private Issuer
8:04am
6-K
EX-99.2
3cda07
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
wt3pszj9j
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
EX-99.1
97subh i0e3p
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
6-K
EX-99.1
oijus11fycvcxxqfj7fo
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
EX-99.1
kp0a1k zjjvrsr7n0f
5 May 22
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra
8:35am
6-K
EX-99.1
v2v2t
29 Apr 22
Report of Foreign Private Issuer
8:15am
F-3
wc37rf2vhx01wza63
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
8t41r 5zkhahs2
8 Mar 22
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
8:03am
6-K
EX-99.1
ng6kvdu8 nt
22 Feb 22
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi, M.D., as Vice President, Medical
8:01am
6-K
EX-99.1
6q08kulbqq xq
13 Dec 21
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients into Greece
8:00am
6-K
EX-99.1
l91uvrc7r3d1idy
7 Dec 21
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
8:01am
6-K
EX-99.1
snrkgd47 bj
6 Dec 21
Enlivex Receives Notice of Allowance for U.S. Patent Application
8:00am
6-K
EX-99.1
yrkrfs 3bb361upl
22 Nov 21
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.2
vulxh
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm